RP 1.25 > (Ramipril 1.25 mg)
Pill with imprint RP 1.25 > is White & Yellow, Capsule-shape and has been identified as Ramipril 1.25 mg. It is supplied by Cobalt Laboratories Inc.
Ramipril is used in the treatment of high blood pressure; left ventricular dysfunction; diabetic kidney disease; heart failure; cardiovascular risk reduction and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Ramipril 1.25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RP 1.25 >
Ramipril
- Imprint
- RP 1.25 >
- Strength
- 1.25 mg
- Color
- White & Yellow
- Size
- 14.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Angiotensin converting enzyme inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cobalt Laboratories Inc
- Inactive Ingredients
-
corn starch,
gelatin,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 16252-0570 | Cobalt Laboratories, Inc. |
| 68084-0294 | Amerisource Health Services |
| 54868-5896 | Physicians Total Care Inc. (repackager) |
Related Images for "RP 1.25 >"
More about ramipril
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 99 Reviews
- Drug class: Angiotensin Converting Enzyme Inhibitors
- FDA Alerts (1)
Consumer resources
- Other brands
- Altace
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.